Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Status Not yet recruiting

Clinical Trial Summary

This study aims to retrospective investigate the safety and effectiveness of Efgartigimod in the acute phase of neuromyelitis optica spectrum disorders (NMOSD) patients.

Clinical Trial Description

This is a multicentre, controlled, retrospective, real-world study which aims to compare the safety and effectiveness of Intravenous methylprednisolone (IVMP) with Efgartigimod injection add-on treatment with IVMP treatment in acute NMOSD patients. Twenty-four patients from 6 centres in China will be enrolled. ;

Study Design

Related Conditions & MeSH terms

Neuromyelitis Optica

Clinical Trial Details

NCT number	NCT06118398
Study type	Observational
Source	First Affiliated Hospital of Chongqing Medical University
Contact	Jinzhou Feng, Ph.D
Phone	02389012487
Email	203756@cqmu.edu.cn
Status	Not yet recruiting
Phase
Start date	November 5, 2023
Completion date	May 5, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02283671` - Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B	Phase 1
Recruiting	`NCT01024985` - Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct	N/A
Recruiting	`NCT04601142` - Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism
Completed	`NCT03942952` - PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
Recruiting	`NCT05573711` - Restless Legs Syndrome in People With Neuromyelitis Optica Spectrum Disorder
Recruiting	`NCT05566769` - Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD	N/A
Withdrawn	`NCT03829566` - Autologous Transplant To End NMO Spectrum Disorder	Phase 2/Phase 3
Recruiting	`NCT05403138` - Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
Completed	`NCT03350633` - Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
Recruiting	`NCT05356858` - An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients	Phase 2
Recruiting	`NCT05982925` - Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Active, not recruiting	`NCT00445367` - Biobank For MS And Other Demyelinating Diseases
Terminated	`NCT02398994` - A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis	Phase 3
Withdrawn	`NCT02087813` - Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses	Phase 1
Terminated	`NCT01339455` - Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica	Phase 1/Phase 2
Recruiting	`NCT02021825` - Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders	Phase 4
Active, not recruiting	`NCT04614454` - High Frequency Impulse Therapy for Neuropathic Pain in NMOSD	Phase 2
Recruiting	`NCT03370965` - Optic Neuritis Differential Diagnosis Study	N/A
Completed	`NCT01777412` - Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations	Phase 1
Recruiting	`NCT01623076` - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders